Aussies who are classified as 'moderate to high risk' and are aged between 18 and 64 now qualify for the immunisation.

More than 200,000 Australians will now be eligible for a free shingles vaccinations, as the government expands their immunisation program.

More than 200,000 Australians who are immunocompromised will gain free access to the shingles vaccine in an expansion of a ...

“By expanding eligibility for the free shingles vaccination, the Albanese Government is protecting more at-risk Australians from this debilitating virus.” Shingles is a viral infection that causes a ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

GSK (GSK) reached the main goal in a Phase 3 trial for its RSV shot, Arexvy co--administered with Shingles vaccine Shingrix.

In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses ...

GSK recorded positive topline data in a late stage trial of its respiratory syncytial virus vaccine combined with a shingles vaccine in treating adults 50 years and older.

Trial met primary endpoint, non-inferior immune response for both vaccines when co-administered compared with separate ...

University of Sydney research has found people over 65 are being prescribed antidepressants as pain treatment based on ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...